When was Aitiologic founded?

Aitiologic was founded in 2023 and raised its 1st funding round 1 year after it was founded.

Where is Aitiologic located?

Aitiologic is headquartered in Wien, Austria.

Who is the current CEO of Aitiologic?

Andreas Posch of Aitiologic. They have also founded 1 company.

How many employees does Aitiologic have?

As of Mar 01, 2026, the latest employee count at Aitiologic is 10 - 49.

Is Aitiologic a funded company?

Aitiologic is a funded company, having raised a total of $9.79M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Oct 01, 2024.

When was the latest funding round of Aitiologic?

Aitiologic's latest funding was a $***** Seed round on Sep 15, 2026, with participation from 4 investors. Its primary sector is Healthcare IT. In Austria, the Healthcare IT sector has seen $38.9M in funding in 2026 to date.

Where does Aitiologic rank among its competitors?

Aitiologic ranks 1st amongst 106 active competitors, of which 19 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Aitiologic, which secured $7M in Sep, 2026.

Who are the top competitors of Aitiologic?

Aitiologic's top competitors include Cent, Renalytix Tech and dehaze. Among them, Aitiologic secured the most recent funding round in September, 2026.

Aitiologic - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-powered solutions for early disease detection and targeted therapy. The company utilizes patented multi-omics technology, which integrates various biological data types to provide a comprehensive understanding of health and disease at the molecular level.

Key Metrics

Founded Year

2023

Location

Wien, Austria

Stage

Seed

Total Funding

$9.79M in 2 rounds

Latest Funding Round

Seed, Sep 15, 2026, $*****

Investors

Austria Wirtschaftsservice & 5 more

Ranked

1^st among 106 active competitors

Employee Count

10 - 49 as on Mar 01, 2026

Similar Companies

Neuron23 & 150 more

View Aitiologic's full profile

Aitiologic has raised a total funding of $9.79M over 2 rounds. Its first funding round was on Oct 01, 2024. Its latest funding round was a Seed round on Sep 15, 2026 for $*****. 4 investors participated in its latest round. Aitiologic has 6 institutional investors.

Here is the list of recent funding rounds of Aitiologic:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2026	6294966	Seed	8123968	2156291	3772599	3099788
Oct 01, 2024	8719674	Seed	7703993	3015570	Austria Wirtschaftsservice & 1 more	PUSH

Access funding benchmarks and valuations. Sign up today!

View details of Aitiologic's funding rounds and investors

The founders of Aitiologic are Andreas Posch and Stephan Beisken. Andreas Posch is the CEO of Aitiologic.

Here are the details of Aitiologic's key team members:

Andreas Posch: Founder & CEO of Aitiologic.
Stephan Beisken: Co-Founder & Cto of Aitiologic.

View details of Aitiologic's Founder profiles and Board Members

Aitiologic's employee count trend

Aitiologic has 10 - 49 employees as of Mar 26. Here is Aitiologic's employee count trend over the years:

Uncover Aitiologic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aitiologic include Cent, Renalytix Tech and dehaze. Here is the list of Top 10 competitors of Aitiologic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aitiologic 2023, Wien (Austria), Seed	AI-powered solutions for early disease detection and targeted therapy	$9.79M	FFG, Ananda Impact Ventures & 4 others	51/100
2nd	Cent 2025, Bengaluru (India), Seed	Provider of a preventive healthcare platform to detect serious diseases using AI and advanced diagnostics	$5M	OneFlow Holdings, South Park Commons	50/100
3rd	Renalytix Tech 2018, New York (United States), Public	Provider of AI-based kidney disease diagnosis tool for healthcare professionals	-	-	45/100
4th	dehaze 2023, Munich (Germany), Seed	AI-powered platform for precise diagnostics and prognostics	$3.75M	DN Capital, YZR Capital & 4 others	44/100
5th	Meta 2020, Dublin (Ireland), Seed	AI-based disease diagnosis tool for providers	$2.2M	Angel Invest Ventures, Enterprise Ireland ... & 2 others	43/100
6th	Kahun 2018, Tel Aviv (Israel), Seed	Provider of an AI-based diagnostic tool for healthcare professionals	$13M	LocalGlobe, EIC Fund & 3 others	41/100
7th	lifespin 2017, Regensburg (Germany), Seed	Cloud and AI-based health diagnostic tool for providers	$634K	Discovery Ventures, Wieland Capital & 1 others	39/100
8th	HAII 2016, Seoul (South Korea), Series B	AI powered digital biomarkers and diagnostic digital devices	$5.53M	KB Securities, KB Investment & 8 others	39/100
9th	TİTRA Technology 2020, Cankaya (Turkey), Acquired	AI-based disease diagnosis tool for providers	-	Kube VC, Odtuteknokent	38/100
10th	Carenostics 2021, United States, Seed	AI-based disease diagnosis tool	$5M	M13 Company, Gaingels & 2 others	37/100